There is indeed a kind of overlap between the approach in the article and phage therapy, which is to clone the lytic enzymes present in the phages and use the p

There is indeed a kind of overlap between the approach in the article and phage therapy, which is to clone the lytic enzymes present in the phages and use the purified products directly on bacteria (I worked on characterizing these things during my PhD). Actually there are some bacteriocins that are homologous to their phage equivalents, and so at a molecular level these two efforts are basically the same. Further reading for the interested: http://www.ncbi.nlm.nih.gov/pubmed/16125935 http://www.ncbi.nlm.nih.gov/pubmed/16125935